Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event
1 other identifier
observational
88
0 countries
N/A
Brief Summary
AstraZeneca was interested in knowing how Cardiologists and Physicians treat patients who have suffered a cardiovascular event.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2010
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2010
CompletedFirst Submitted
Initial submission to the registry
June 14, 2011
CompletedFirst Posted
Study publicly available on registry
July 15, 2011
CompletedAugust 30, 2011
August 1, 2011
6 months
June 14, 2011
August 29, 2011
Conditions
Eligibility Criteria
Patients with cardiovascular events
You may qualify if:
- All patients who has experienced cardiovascular events
You may not qualify if:
- Patients with no cardiovascular events.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
Study Design
- Study Type
- observational
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 14, 2011
First Posted
July 15, 2011
Study Start
January 1, 2010
Primary Completion
July 1, 2010
Study Completion
July 1, 2010
Last Updated
August 30, 2011
Record last verified: 2011-08